Characterization and Potential Mitigation of Corneal Effects in Nonclinical Toxicology Studies in Animals Administered Depatuxizumab Mafodotin

Journal of Ocular Pharmacology and Therapeutics. 2022 Sep 1;38(7):471-80

Published Date

2022-01-01

Associated Team Member

2022

01

Loberg LI, Henriques TA, Johnson JK, Miller PE, Ralston SL

Investigation Type

Therapy Development

Development Phase

Therapy Class

Antibody-Drug Conjugates

Ophthalmic Exam